Hans-Peter Gerber
PhD
Chief Scientific Officer
👥Biography 个人简介
Hans-Peter Gerber has led oncology research and ADC programs at several major biopharma companies. His work spans antibody engineering, conjugate design, and clinical translation. He has published on tumor targeting strategies and ADC mechanism of action. He is recognized for contributions to both ADC and bispecific antibody platforms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hans-Peter Gerber 的研究动态
Follow Hans-Peter Gerber's research updates
留下邮箱，当我们发布与 Hans-Peter Gerber（Maverick Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment